Abstract:RATIONALE:Asthma is a chronic inflammatory disorder with a characteristic of airway hyperresponsiveness (AHR). Ca(2+)-activated Cl(-) [Cl((Ca))] channels are inferred to be involved in AHR, yet their molecular nature and the cell type they act within to mediate this response remain unknown.OBJECTIVES:Transmembrane protein 16A (TMEM16A) and TMEM16B are Cl((Ca)) channels, and activation of Cl((Ca)) channels in airway smooth muscle (ASM) contributes to agonist-induced airway contraction. We hypothesized that Tmem16a and/or Tmem16b encode Cl((Ca)) channels in ASM and mediate AHR.METHODS:We assessed the expression of the TMEM16 family, and the effects of niflumic acid and benzbromarone on AHR and airway contraction, in an ovalbumin-sensitized mouse model of chronic asthma. We also cloned TMEM16A from ASM and examined the Cl(-) currents it produced in HEK293 cells. We further studied the impacts of TMEM16A deletion on Ca(2+) agonist-induced cell shortening, and on Cl((Ca)) currents activated by Ca(2+) sparks (localized, short-lived Ca(2+) transients due to the opening of ryanodine receptors) in mouse ASM cells.MEASUREMENTS AND MAIN RESULTS:TMEM16A, but not TMEM16B, is expressed in ASM cells and its expression in these cells is up-regulated in ovalbumin-sensitized mice. Niflumic acid and benzbromarone prevent AHR and contraction evoked by methacholine in ovalbumin-sensitized mice. TMEM16A produces Cl((Ca)) currents with kinetics similar to native Cl((Ca)) currents. TMEM16A deletion renders Ca(2+) sparks unable to activate Cl((Ca)) currents, and weakens caffeine- and methacholine-induced cell shortening.CONCLUSIONS:Tmem16a encodes Cl((Ca)) channels in ASM and contributes to Ca(2+) agonist-induced contraction. In addition, up-regulation of TMEM16A and its augmented activation contribute to AHR in an ovalbumin-sensitized mouse model of chronic asthma. TMEM16A may represent a potential therapeutic target for asthma.

Relationship between calcium-activated chloride channels and mucus overproduction,allergic airway inflammation in asthma

S100A4 is Critical for a Mouse Model of Allergic Asthma by Impacting Mast Cell Activation.

Sonic Hedgehog (shh) and CC Chemokine Ligand 2 Signaling Pathways in Asthma

The Transmembrane Protein 16A Ca(2+)-activated Cl- Channel in Airway Smooth Muscle Contributes to Airway Hyperresponsiveness.

Role of Aquaporin 5 in Antigen-Induced Airway Inflammation and Mucous Hyperproduction in Mice

Chloride intracellular channel 4 participates in the regulation of lipopolysaccharide-induced inflammatory responses in human bronchial epithelial cells

AQP5 role in ovalbumin-induced airway inflammation and secretion of MUC5AC in mice

Regulation of MUC5AC Mucin Secretion by Depletion of AQP5 in SPC-A1 Cells

Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma

Mycoplasma Pneumoniae and Bronchial Asthma

YKL-40 (BRP-39) and Bronchial Asthma

Egr-1 Regulates Muc5ac Expression Through Activator Protein-1 (AP-1) in Chronic Airway Inflammation Diseases

Clara cell 10 (CC10) protein attenuates allergic airway inflammation by modulating lung dendritic cell functions

Eosinophil-derived chemokine (hCCL15/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation

Monocyte chemotactic protein-inducing protein 1 negatively regulating asthmatic airway inflammation and mucus hypersecretion involving γ-aminobutyric acid type A receptor signaling pathway in vivo and in vitro

CXCR3 and its ligands are associated with bronchial asthma

Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13-stimulated airway epithelial cells

Induction of MUC5AC Mucin Expression by Histamine Through the Activation of Its Core Promoter Region.

Asthmatic Airway Vagal Hypertonia Involves Chloride Dyshomeostasis of Preganglionic Neurons in Rats

Disease-specific transcriptional programs govern airway goblet cell metaplasia

Expression of AQP5 and MUC5AC and Their Relationship in Lung Rat Asthma Model